CAS: 13269-35-7 - R-(+)-Hyoscyamine
Fórmula:C17H23NO3
InChI:InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15+,16-/m0/s1
Clave InChI:InChIKey=RKUNBYITZUJHSG-JJXSEGSLSA-N
SMILES:O=C(OC1CC2N(C)C(CC2)C1)C(C=3C=CC=CC3)CO
- Sinónimos:
- (+)-Atropine
- (+)-Hyoscyamine
- (R)-Atropine
- 8-methyl-8-azabicyclo[3.2.1]oct-3-yl (2R)-3-hydroxy-2-phenylpropanoate
- <span class="text-smallcaps">D</span>-Hyoscyamine
- Benzeneacetic acid, α-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, (αR)-
- Benzeneacetic acid, α-(hydroxymethyl)-, 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester, [3(R)-endo]-
- d-Atropine
- d-Hyoscyamine
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
D-Atropine-d5 REF: 4Z-A-151030CAS: 13269-35-7 | - - - | A consultar | Mar 14 Ene 25 | |
D-Atropine REF: 4Z-A-151029CAS: 13269-35-7 | - - - | A consultar | Mar 14 Ene 25 | |
D-Hyoscyamine REF: TR-H674303CAS: 13269-35-7 | - - - | 2.167,00 € | Mar 18 Feb 25 | |
D-Hyoscyamine REF: 3D-NAA26935CAS: 13269-35-7 | Min. 95% | A consultar | Mar 01 Abr 25 |
Ref: 4Z-A-151030
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
Ref: 4Z-A-151029
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
D-Hyoscyamine
Producto controladoCAS:13269-35-7
Fórmula:
C17H23NO3
Forma y color:
Neat
Peso molecular:
289.369
Ref: TR-H674303
25mg | 2.167,00 € |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
D-Hyoscyamine
CAS:13269-35-7
D-Hyoscyamine is a potent anticancer agent that has been shown to induce apoptosis in cancer …
Fórmula:
C17H23NO3
Pureza:
Min. 95%
Peso molecular:
289.4 g/mol
Ref: 3D-NAA26935
10mg | 2.898,00 € | ||
25mg | 3.478,00 € | ||
50mg | 4.405,00 € | ||
100mg | 4.869,00 € |
Entrega estimada en Estados Unidos, el Martes 1 de Abril de 2025